Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
N/A
Synonyms :
trebananib
Class :
Limited data available
Data not availableÂ
It is an investigational drug, and its status or recommended dosage may change, and it is an angiogenesis inhibitor that targets the angiopoietin axis and was being studied for its potential use in various cancers, including ovarian cancer
Data not availableÂ
Refer to adult dosingÂ
the risk of anti-angiogenesis and jaw osteonecrosis may be increased
the risk of methemoglobinemia can be increased
the risk of methemoglobinemia can be increased
the risk of methemoglobinemia can be increased
the risk of methemoglobinemia can be increased
the risk of methemoglobinemia can be increased
the risk of methemoglobinemia can be increased
the risk of methemoglobinemia can be increased
the risk of methemoglobinemia can be increased
the risk of anti-angiogenesis and jaw osteoporosis may be increased
the risk of methemoglobinemia can be increased
the risk of immunosuppression may be increased
the risk of anti-angiogenesis and jaw osteoporosis may be increased
the risk of methemoglobinemia can be increased
the risk of methemoglobinemia can be increased
the risk of methemoglobinemia can be increased
the risk of methemoglobinemia can be increased
the risk of methemoglobinemia can be increased
the risk of methemoglobinemia can be increased
the risk of anti-angiogenesis and jaw osteoporosis may be increased
the risk of anti-angiogenesis and jaw osteoporosis may be increased
Actions and spectrum:Â
Trebananib is known to inhibit angiogenesis by blocking the interaction between Ang1/Ang2 with the Tie2 receptorÂ
Frequency not definedÂ
RashÂ
FatigueÂ
MucositisÂ
Black Box WarningÂ
None Â
Contraindication/Caution:Â
None
 Â
Pregnancy consideration:Â Â
USFDA pregnancy category: not assignedÂ
Lactation:Â Â
The data about the excretion of trebananib into human milk is not knownÂ
Pregnancy category:Â Â
Pharmacology:Â
Under investigationÂ
Patient information leafletÂ
Generic Name: trebananibÂ
Why do we use trebananib?Â
trebananib is used for fallopian tube cancer, peritoneal cancer, and ovarian cancer. Still this drug is under investigation.Â